Glad

Davanrik was developed to treat depression. However it was later found proscribed that it also affected the hunger of the person and could be teach as a do medicates for obesity patient roles. Davanrik was currently in the pre-clinical development stage when it was offered to Merck to licence it. Since research laboratory was a subaltern company could not afford to get it by means of the FDA citation process. LAB offered to give the rights to Merck if pay it an initial pay rundown tiptoe on each stage and deliberate the drug through the entire FDA approval stage, manufacture the drug, commercialize the drug and pay a royalty on exclusively gross revenue to LAB. Clinical Approval Stages In flesh 1, the drug would be administered to 20-80 healthy volunteers to test for safety. The stage would take 2 years. If Merck opinionated to go ahead with the first phase investment, it would cost $30 jillion including an initial $5 one thousand million fee to LAB for licens ing the drug. Probability of success of microscope stage 1 is 60%. In Phase 2, a larger number (100-300) of patient volunteers argon tested to determine if the drug is effective or not. Does the recitation of drug have any side effectuate on patients. It was estimated that there is only 10% prospect that Phase 2 would show that Davanrik would be effective for depression only, 15% opportunity for weight loss only, and a 5% probability for both(prenominal) depression and weight loss. This phase would also require 2 years and would cost $40 million including a $2.5 million licensing milestone payment to LAB.If you want to get a teeming essay, order it on our website: OrderCustomPaper.com

If you want to get a full essay, visit our page: write my paper